A letter to life sciences organizations
Dr. Brian Solow, chief medical officer of Optum Life Sciences, addresses the importance of collaboration across the global health care spectrum to drive solutions for a healthier tomorrow.
Life sciences companies are at the forefront of trying to solve the novel coronavirus disease 2019 (COVID-19) pandemic.
From creating diagnostic tests and preventative vaccines, to finding treatment options from emerging and existing medicines, you are tirelessly working to find solutions that will help give health care providers the tools they need to save patients' lives.
Like you, Optum is concerned about the impact of this pandemic on the health and well-being of patients, and the safety of our team members and loved ones.
We are devoting significant effort and resources across the enterprise to respond to this serious situation, including rapid response needs for real-time, real-world data assets to support and strengthen your efforts around COVID-19:
• Investigating emerging health issues and trends from our de-identified EHR and claims data
• Supporting design of clinical studies and patient finding for long-term outcomes studies
• Understanding the patient’s treatment journey, and insight into the patient population
• Developing early programs in collaboration with life sciences companies, payers, providers and patients to improve care and the associated burdens
These are challenging times. The people and health systems we serve are counting on us to work together, and with others in health care, to perform at our very best. We'll continue to be in regular communication with you as this pandemic evolves.
You were made for this. Optum was made for this. Let's connect today and start collaborating on solutions. Be well, and stay safe.
Brian Solow, MD
Chief Medical Officer, Optum Life SciencesOR
Optum life sciences capabilities
Real-time COVID data
- Identify early signs and symptoms
- Visibility across encounters, including use of telemedicine
- Hospitalization cases, severity including ventilator use and duration
The power of Optum
- Understand lessons learned within the world’s largest health care company
- Leverage expertise from the payer, provider and pharmacy markets
Drug Safety Surveillance
- Early detection of epidemiology outcomes and their impact to patients
- Understand pregnant mother and child risk, medication use and outcome
Clinical literature evaluation
- Identify and summarize existing treatment patterns and medical literature
- Quickly highlight which drugs and patterns of care are most efficacious in the pandemic
- Answer critical research questions leveraging real-time, real-world data
- Investigate characteristics of patients and their outcomes to generate hypotheses and prioritize research efforts
- Evaluate comparative effectiveness of patients treated with your product versus a competitor's product
Change clinical care
- Identify and launch clinical programs focused on closing gaps in care
- Identify future areas and population impact
Digital Research Network
- Create prospective synthetic control arms for clinical trials where a comparator arm is not feasible
- Construct retrospective virtual cohort to match characteristics of patient populations in prior clinical trials
The voice of the patient
- Measure and understand health-related quality of life (HRQoL), including mental and physical health impacts
- Leverage a world-wide leader in patient-reported outcomes
- Understand market dynamics
- Enable more effective commercialization of current or future treatments/vaccines
Optum dashboard: COVID-19 data insights
Optum real-world COVID-19 patient dataset can be used to help answer your most pressing research questions and uncover critical insights. This specialized dashboard provides top-line, clinically relevant information about total active patient cases, total recovered patients, those newly symptomatic and more.
The great data transition: making the move from claims to EHR data
As talk of pandemics and population health trends fill our days, this white paper walks you through the ways claims data answers the hows, while EHR data gets to the whys. Learn how the immediacy of EHR data availability can be significantly impactful, particularly as the health care system works to address COVID-19.